Target intelligence / Profile preview

Plasmodium falciparum redox network proteins

Molecular classification
Enzyme, Oxidoreductase
01

Overview

The Plasmodium falciparum redox network proteins represent a complex array of enzymes and antioxidant molecules essential for the survival of the malaria parasite during its intraerythrocytic stage. This network primarily consists of the thioredoxin and glutathione systems, which work in tandem to maintain intracellular thiol-disulfide homeostasis and neutralize reactive oxygen species (ROS) generated by hemoglobin digestion and host immune responses (Müller et al., 2003). Key enzymes such as thioredoxin reductase (PfTrxR) and glutathione reductase (PfGR) are central to these pathways, providing the reducing equivalents necessary for DNA synthesis and the repair of oxidatively damaged proteins (Becker et al., 2004). Because the parasite lacks a catalase and has a limited repertoire of antioxidant enzymes compared to its human host, it is particularly vulnerable to oxidative stress (Jortani et al., 2020). Therapeutic strategies targeting this network often involve the use of inhibitors like methylene blue or auranofin, which disrupt the parasite's ability to manage oxidative loads, leading to rapid parasite death (Buchholz et al., 2008). However, drug development must account for the high degree of similarity between some parasite enzymes and their human counterparts to avoid off-target toxicity, particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency (Sarma et al., 2003).

Other names
Plasmodium falciparum antioxidant systemPf redox metabolismThioredoxin-glutathione system of P. falciparumPlasmodium falciparum redox homeostasis proteins
02

Mechanism of action

Inhibition of key oxidoreductase enzymes, specifically thioredoxin reductase and glutathione reductase, to disrupt thiol-disulfide homeostasis and induce lethal oxidative stress within the parasite (Becker et al., 2004; Müller et al., 2003).

03

Biological functions

Redox homeostasisOxidative stress responseDNA synthesisProtein foldingHeme detoxification
04

Disease associations

Infection
05

Safety considerations

Hemolytic anemia in G6PD-deficient patientsSelectivity over human redox enzymesPotential for drug-drug interactions with other oxidative agents
06

Interacting drugs

Methylene blue

4 more in the full profile.

07

Biomarkers

ParasitemiaReduced-to-oxidized glutathione ratio (GSH/GSSG)Malondialdehyde (MDA) levelsPlasmodium falciparum histidine-rich protein 2 (PfHRP2)

Beyond the preview

Go deeper on Plasmodium falciparum redox network proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum redox network proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call